Kahn Brothers Group Inc – NVS history
- Issuer:
- Novartis AG Sponsored ADR
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 13,386
- Current value:
- $2.04M
- Peak shares:
- 21,909 (Q1 2025)
- Overall change:
- -26%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 13,386 | $2.04M | $152.77 | -292 | -2% |
| Q4 2025 | 13,678 | $1.89M | $137.89 | -648 | -5% |
| Q3 2025 | 14,326 | $1.84B | $128239.98 | 0 | 0% |
| Q3 2025 | 14,326 | $1.84M | $128.23 | -4,145 | -22% |
| Q2 2025 | 18,471 | $2.23M | $121.00 | 0 | 0% |
| Q2 2025 | 18,471 | $2.24B | $121009.96 | -3,438 | -16% |
| Q1 2025 | 21,909 | $2.44M | $111.51 | 0 | 0% |
| Q1 2025 | 21,909 | $2.44B | $111496.46 | +728 | +3% |
| Q4 2024 | 21,181 | $2.06M | $97.30 | 0 | 0% |
| Q4 2024 | 21,181 | $2.06B | $97293.42 | +3,600 | +20% |
| Q3 2024 | 17,581 | $2.02B | $115011.89 | 0 | 0% |
| Q2 2024 | 17,581 | $1.87B | $106464.48 | +2,168 | +14% |
| Q1 2024 | 15,413 | $1.49B | $96741.45 | -2,650 | -15% |
| Q4 2023 | 18,063 | $1.82B | $100988.98 | — | NEW |